| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/21/2001 | CN1284332A Onychomycosis cream and its production process |
| 02/21/2001 | CN1284330A Medicinal aerosol preparation, its preparing method and release |
| 02/21/2001 | CN1284329A Oil dispersed preparation of oil insoluble medicine |
| 02/21/2001 | CN1062181C Compound sophore flavescens injection |
| 02/21/2001 | CN1062170C Lactation-promoting granulae and its processing method |
| 02/21/2001 | CN1062165C Eye ointment for curing myopia and amblyopia |
| 02/21/2001 | CN1062163C Magnetic disinfectant antipruritic spray for preventing and curing venereal disease |
| 02/21/2001 | CN1062161C Process for preparation of stable fleabane extract injection |
| 02/21/2001 | CN1062156C Drug for preventing and treating tinea, smelly foot and infections skin disease |
| 02/21/2001 | CN1062155C Oral liquid of purslane speedwell and preparation thereof |
| 02/21/2001 | CN1062154C Method for producing chinese patent medicine and its pill for curing diabetes |
| 02/21/2001 | CN1062150C Method for producing plaster for treating and preventing hyperosteogeny |
| 02/21/2001 | CN1062148C Compound jiabing ear drops and preparation method thereof |
| 02/21/2001 | CN1062147C Zuochuangjing-external use medicine for treating acne |
| 02/21/2001 | CN1062146C Chinese plaster for treating hernia and its prep |
| 02/21/2001 | CN1062145C Piles curing liquid |
| 02/21/2001 | CN1062144C Yisuishengxue chinese medicine preparation for tonifying marrow and promoting generation of blood |
| 02/21/2001 | CN1062139C Preparation of capsule and instant powder of extracts of wood frog oil |
| 02/21/2001 | CN1062131C Ointment for treatment of silkworker's dermatitis |
| 02/21/2001 | CN1062130C Medical liposome ointment |
| 02/21/2001 | CN1062129C Medicine matrix and its use |
| 02/21/2001 | CN1062128C Ointment for eliminating tinea |
| 02/21/2001 | CN1062127C Freckle dispelling powder |
| 02/21/2001 | CA2378378A1 Strip pack |
| 02/20/2001 | US6191339 Thermal effect patch and the use thereof |
| 02/20/2001 | US6191335 Backing layer, an apertured wound facing layer and an intermediate absorbent layer comprising fibers of material which upon contact with moisture will form a gel. |
| 02/20/2001 | US6191261 Immunoglobulin that preferential binds a growth factor; for the diagnosis and treatment of cell proliferative defects; antiproliferative agents |
| 02/20/2001 | US6191172 Used in drugs and cosmetics |
| 02/20/2001 | US6191162 Administering lipoic acid |
| 02/20/2001 | US6191149 Heterocyclic derivative and medicine |
| 02/20/2001 | US6191137 Pharmaceutical composition for oral administration |
| 02/20/2001 | US6191121 Treatment of skin damage using polyenylphosphatidylcholine |
| 02/20/2001 | US6191120 Spermicidally active 5-halo-6-alkoxy-5,6-dihydro-2′,3′-dideoxy-uridines and their pharamaceutical compositions |
| 02/20/2001 | US6191107 Complexes with biodregadable polymers |
| 02/20/2001 | US6191105 Insulin free compositions with insulin-methyl(ethylene glycol)-o-hexanoic acid conjugate and composition with water in oil microemulsion |
| 02/20/2001 | US6190869 Antisense inhibition of protein kinase C-theta expression |
| 02/20/2001 | US6190702 Sustained-released material prepared by dispersing a lyophilized polypeptide in an oil phase |
| 02/20/2001 | US6190701 For delivering vaccines and drugs |
| 02/20/2001 | US6190700 Production of sustained-release preparation for injection |
| 02/20/2001 | US6190699 Method of incorporating proteins or peptides into a matrix and administration thereof through mucosa |
| 02/20/2001 | US6190698 Stability; discoloration inhibition; used as antipsychotic agent |
| 02/20/2001 | US6190697 Dosage form for prophylaxis or therapy; dissolution |
| 02/20/2001 | US6190696 Stabilized thyroxine medications |
| 02/20/2001 | US6190694 Rendering chitosan into powder; adding chitosan powder, powder comprising organic acid and salt thereof, and an emulsifier to an oil or fat; stirring mixture so as to suspend powders, obtain a gel-like stock and gelatin solution for encapsulation |
| 02/20/2001 | US6190692 Time-specific controlled release capsule formulations and method of preparing same |
| 02/20/2001 | US6190690 For treating arthritis, rhumatism |
| 02/20/2001 | US6190689 As device for release of substances (e.g.: acetylsalicylic acid, tobacco powder) from pressure sensitive hot-melt adhesives with a uniform or non-uniform distribution substances |
| 02/20/2001 | US6190687 Method for preparing an extract of active principles in the form of microgranules based on dietary fibers |
| 02/20/2001 | US6190686 Water dispersible compositions containing natural hydrophobic pigment, method of preparing same and their use |
| 02/20/2001 | US6190685 Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same |
| 02/20/2001 | US6190680 Oily composition and process for producing the same |
| 02/20/2001 | US6190673 Gel compositions containing gellants in the form of alkyl amides of tri-carboxylic acids |
| 02/20/2001 | US6190668 Providing cell mass of moraxella catarrhalis strain grown under iron-starved conditions to stimulate transferrin receptor protein expression; selectively extracting aqueous soluble proteins; separation; solubilizing; purification mass |
| 02/20/2001 | US6190591 Continuously, by admixing a matrix with a plasticizer and a release rate control compound under low shear conditions, reducting plasticizer content, cooling, admixing with encapsulant, avoiding thermodegradation; extrusion, cutting |
| 02/20/2001 | CA2316329A1 Additive for improving the water resistance of cosmetic or dermatological formulations |
| 02/20/2001 | CA2176361C Polyhydroxybutyrate and polyphosphate membranes with channels |
| 02/20/2001 | CA2083404C Therapeutically effective topical application of st1435 |
| 02/15/2001 | WO2001011068A2 Cationic lipid compounds and use thereof for transferring negatively charged substances of therapeutic interest |
| 02/15/2001 | WO2001011041A1 MONOMERIC PROTEIN OF THE TGF-β FAMILY |
| 02/15/2001 | WO2001011009A2 Intestinal gene therapy |
| 02/15/2001 | WO2001010934A1 Block copolymer having polymer segment derived from oxazoline |
| 02/15/2001 | WO2001010742A1 Valve with a valve stem wiper |
| 02/15/2001 | WO2001010741A1 Valve with a two-component seal |
| 02/15/2001 | WO2001010481A2 Drug dispensing system |
| 02/15/2001 | WO2001010468A2 Drug-carrier complexes and methods of use thereof |
| 02/15/2001 | WO2001010467A1 Solid preparations containing chitosan powder and process for producing the same |
| 02/15/2001 | WO2001010466A1 Stable medicinal compositions for oral use |
| 02/15/2001 | WO2001010465A1 Moxifloxacin formulation containing common salt |
| 02/15/2001 | WO2001010464A1 Edible holographic products, particularly pharmaceuticals and methods and apparatus for producing same |
| 02/15/2001 | WO2001010463A1 Pastes with the sustained release of osteogenesis promoter |
| 02/15/2001 | WO2001010452A1 Frozen product and method of oral delivery of active ingredients |
| 02/15/2001 | WO2001010447A1 Use of rhamnolipids in wound healing, treatment and prevention of gum disease and periodontal regeneration |
| 02/15/2001 | WO2001010446A2 Formulations for parenteral use of estramustine phosphate and albumin |
| 02/15/2001 | WO2001010443A1 Pharmaceutical formulations in hydroxypropylmethylcellulose capsules |
| 02/15/2001 | WO2001010435A1 Patch |
| 02/15/2001 | WO2001010431A2 Headache and colic relief composition with asafetida and method of use thereof |
| 02/15/2001 | WO2001010430A2 Use of estrogen compounds for prevention and treatment of ischemic damage |
| 02/15/2001 | WO2001010427A2 Use of anti-muscarinic agents for treating skin disorders |
| 02/15/2001 | WO2001010421A1 Drug releasing biodegradable fiber implant |
| 02/15/2001 | WO2001010420A1 Transdermal patch comprising methylphenidate |
| 02/15/2001 | WO2001010419A1 Hydrodynamically balancing oral drug delivery system |
| 02/15/2001 | WO2001010418A1 Means for creating a mass having structural integrity |
| 02/15/2001 | WO2001010417A1 Floating pharmaceutical composition comprising an active phase and a non-active phase |
| 02/15/2001 | WO2001010416A1 Method of delivering a chemotherapeutic agent to a solid tumor |
| 02/15/2001 | WO2001010415A1 A binder for pharmaceutical compositions |
| 02/15/2001 | WO2001010414A1 Slow release microspheres |
| 02/15/2001 | WO2001010413A2 Periodic structures comprising lipids, polyelectrolytes, and structures-inducing soluble oligovalent linkers |
| 02/15/2001 | WO2001010412A1 Epothilone compositions |
| 02/15/2001 | WO2001010411A2 Implantable active ingredient depot |
| 02/15/2001 | WO2001010410A1 Non-crystalline cefuroxime axetil solid dispersant, process for preparing same and composition for oral administration thereof |
| 02/15/2001 | WO2001010409A1 Aqueous nasal formulation |
| 02/15/2001 | WO2001010408A2 Aqueous pharmaceutical composition containing moxifloxacin or salts thereof |
| 02/15/2001 | WO2001010407A1 Intravaginal clindamycin ovule composition |
| 02/15/2001 | WO2001010406A2 Facilitating the preservation of sight by increasing optic nerve, choroidal and retinal blood flow |
| 02/15/2001 | WO2001010405A1 Hydrodynamically balanced oral drug delivery system |
| 02/15/2001 | WO2001010239A1 Ingestible chewing gum for animals |
| 02/15/2001 | WO2000078288A3 Novel process for paroxetine compositions |
| 02/15/2001 | WO2000061184A3 Dry formulation for transcutaneous immunization |
| 02/15/2001 | WO2000059483A3 Transdermal drug delivery devices comprising a polyurethane drug reservoir |
| 02/15/2001 | WO2000057852A3 Methods and compositions for treating solid tumors |